The Architectural Turn in Depression Why Network Topology Will Define the Next Era of CNS Strategy
Denis Katz, MD, MHAFounder, Salience Clinical
Reframing Depression: Beyond Chemistry
For much of modern psychiatry, major depressive disorder (MDD) has been understood through the lens of neurochemistry—an imbalance in serotonin, norepinephrine, or dopamine signaling. This paradigm has driven decades of therapeutic innovation.
But its limitations are now clear.
A significant...